LifeLabs Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:LifeLabs Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10783
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LifeLabsInc (LifeLabs), formerly MDS Diagnostic Services is a laboratory service provider that diagnoses, treats, monitors and prevent diseases in patients. The laboratory’s services include clinical studies and services, drug and alcohol screening, employee wellness, hospital lab services, medical surveillance, occupational health services, specialized clinical lab testing, cardiac monitoring and mobile lab services, among others. It offers a broad range of community laboratory tests to clinical test centers, hospitals, employers, insurers and government agencies. The company works in partnerships with charitable organizations for health research, education and technology and improvements to treat and manage diseases. LifeLabs is headquartered in Toronto, Ontario, Canada.

LifeLabs Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LifeLabs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LifeLabs Inc, Medical Devices Deals, 2012 to YTD 2018 8
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
LifeLabs Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
LifeLabs Medical Labs Acquires Genteic Testing Business Of Centogene 10
Partnerships 12
LifeLabs Enters Co Marketing Agreement With Contextual Genomics 12
Asset Transactions 13
Gamma-Dynacare Medical Acquires Quebec Operations Of Lifelabs 13
Acquisition 14
LifeLabs Completes Acquisition Of BC Biomedical, Lab Services Provider 14
LifeLabs Inc – Key Competitors 15
LifeLabs Inc – Key Employees 16
LifeLabs Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Dec 15, 2017: LifeLabs to deliver laboratory collection services in Saskatchewan 18
Corporate Communications 19
May 01, 2018: LifeLabs Announces New President and CEO 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
LifeLabs Inc, Pharmaceuticals & Healthcare, Key Facts 2
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LifeLabs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LifeLabs Inc, Medical Devices Deals, 2012 to YTD 2018 8
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
LifeLabs Medical Labs Acquires Genteic Testing Business Of Centogene 10
LifeLabs Enters Co Marketing Agreement With Contextual Genomics 12
Gamma-Dynacare Medical Acquires Quebec Operations Of Lifelabs 13
LifeLabs Completes Acquisition Of BC Biomedical, Lab Services Provider 14
LifeLabs Inc, Key Competitors 15
LifeLabs Inc, Key Employees 16
LifeLabs Inc, Other Locations 17
LifeLabs Inc, Subsidiaries 17

List of Figures
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
LifeLabs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LifeLabs Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[LifeLabs Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Quark Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Quark Pharmaceuticals Inc (Quark), a subsidiary of SBI Biotech Co Ltd, is a clinical-stage pharmaceutical company in the development of novel RNAi-based therapeutics. It offers under development products which include PF-655, a synthetic siRNA which is used for the treatment of diabetic macu …
  • Oglethorpe Power Corporation:企業の戦略・SWOT・財務分析
    Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report Summary Oglethorpe Power Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Nanosphere Inc-医療機器分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Perseus Mining Limited:企業の戦略・SWOT・財務情報
    Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report Summary Perseus Mining Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bank of England:企業の戦略・SWOT・財務情報
    Bank of England - Strategy, SWOT and Corporate Finance Report Summary Bank of England - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Green Highland Renewables Ltd:電力:M&Aディール及び事業提携情報
    Summary Green Highland Renewables Ltd (GHRL), formerly Green Highlander Renewables Limited, a subsidiary of Ancala Partners LLP, is a renewable energy company that develops, builds, and maintains hydro electric schemes. The company provides services including site identification, environmental appra …
  • Daicel Corporation (4202):企業の財務・戦略的SWOT分析
    Daicel Corporation (4202) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • BioPorto Diagnostics AS:医療機器:M&Aディール及び事業提携情報
    Summary BioPorto Diagnostics AS (BioPorto Diagnostics), formerly AntibodyShop AS is an in-vitro diagnostics company that manufactures and markets antibodies and antibody based products. The company’s products include matched reagent set, immunoassays, antigens, antibodies, controls calibrators and m …
  • Consolidated Edison Company of New York Inc:電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New Y …
  • Ocean Rig UDW Inc (ORIG):企業の財務・戦略的SWOT分析
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • Pharm-Olam International Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization that offers clinical research services. The organization’s services include clinical trials, medical writing, medical monitoring, regulatory submissions, data management, biostatistics analysis, pharmacovigilance, …
  • Perdana Petroleum Bhd (PERDANA):企業の財務・戦略的SWOT分析
    Perdana Petroleum Bhd (PERDANA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Kansas City Power & Light Co:企業の戦略的SWOT分析
    Kansas City Power & Light Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Intesa Sanpaolo S.p.A:企業のM&A・事業提携・投資動向
    Intesa Sanpaolo S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intesa Sanpaolo S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • China Merchants Securities Co Ltd (600999):企業の財務・戦略的SWOT分析
    China Merchants Securities Co Ltd (600999) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Elong Inc
    Elong Inc - Strategy, SWOT and Corporate Finance Report Summary Elong Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Biolife Solutions Inc (BLFS):企業の財務・戦略的SWOT分析
    Summary BioLife Solutions Inc (BioLife Solutions) is a developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. The company offers serum-free and protein-free solutions, which are formulated to red …
  • Co.don AG (CNWK):医療機器:M&Aディール及び事業提携情報
    Summary Co.don AG (Co.don) offers tissue engineering solutions in cultivation and growth of autologous tissue cells for the regenerative treatment of articular cartilage defects and spinal disc defects. The company manufactures and markets autologous, cell-based pharmaceutical products for biologica …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆